Biblio

Largent-Milnes TM, Guo W, Wang H-Y, Burns LH, Vanderah TW.  2008.  Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling.. J Pain. 9(8):700-13.

Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RDiaz, Nilsen J.  2008.  Progesterone and estrogen regulate oxidative metabolism in brain mitochondria.. Endocrinology. 149(6):3167-75.

Brinton RDiaz, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ et al..  2008.  Progesterone receptors: form and function in brain.. Front Neuroendocrinol. 29(2):313-39.

Wang JMing, Liu L, Irwin RW, Chen S, Brinton RDiaz.  2008.  Regenerative potential of allopregnanolone.. Brain Res Rev. 57(2):398-409.

Streicher JM, Wang Y.  2008.  The role of COX-2 in heart pathology.. Cardiovasc Hematol Agents Med Chem. 6(1):69-79.

Watts GS, Tran NL, Berens ME, Bhattacharyya AK, Nelson MA, Montgomery EA, Sampliner RE.  2007.  Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.. Int J Cancer. 121(10):2132-9.

Goulet A-C, Watts G, Lord JL, Nelson MA.  2007.  Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.. Cancer Biol Ther. 6(4):494-503.

Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.  2006.  AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.. Oncogene. 25(39):5405-15.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW.  2006.  Epigenetic inactivation of the HOXA gene cluster in breast cancer.. Cancer Res. 66(22):10664-70.

Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW.  2006.  Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.. Technol Cancer Res Treat. 5(6):553-64.

D Sparks L, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Browne P, Wasser D, Johnson-Traver S, Lochhead J, Ziolwolski C.  2005.  Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.. Arch Neurol. 62(5):753-7.

D Sparks L, Sabbagh MN, Connor DJ, Lopez J, Launer LJ, Petanceska S, Browne P, Wassar D, Johnson-Traver S, Lochhead J et al..  2005.  Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.. Curr Alzheimer Res. 2(3):343-53.

Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL.  2005.  Serotonin-related gene expression in female monkeys with individual sensitivity to stress.. Neuroscience. 132(1):151-66.

Sparks D.L., Lochhead J., Fisher A., Martin T..  2005.  Water Quality and Cholesterol-induced pathology: differential effects of the M-1 muscarinic receptor agaonist AF267b on accumulation of Alzheimer-like Amyloid B in rabbit brain. Recent Progress in Alzheimer's and Parkinson's Diseases. :197-203.

Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW.  2004.  The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.. Neoplasia. 6(3):187-94.

Ignatenko NA, Zhang H, Watts GS, Skovan BA, Stringer DE, Gerner EW.  2004.  The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.. Mol Carcinog. 39(4):221-33.

Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J.  2004.  Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.. BMC Genomics. 5:61.

Huan J-Y, Streicher JM, Bleyle LA, Koop DR.  2004.  Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.. Toxicol Appl Pharmacol. 199(3):332-43.

Zheng XHui, Watts GS, Vaught S, A Gandolfi J.  2003.  Low-level arsenite induced gene expression in HEK293 cells.. Toxicology. 187(1):39-48.

Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW.  2003.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.. Oncogene. 22(23):3624-34.

Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M et al..  2002.  Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.. Carcinogenesis. 23(12):2063-80.

Bethea CL, Lu NZ, Gundlah C, Streicher JM.  2002.  Diverse actions of ovarian steroids in the serotonin neural system.. Front Neuroendocrinol. 23(1):41-100.

D Sparks L, Lochhead J, Horstman D, Wagoner T, Martin T.  2002.  Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid beta (Abeta) in rabbit brain.. J Alzheimers Dis. 4(6):523-9.

Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE.  2001.  cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.. J Pharmacol Exp Ther. 299(2):434-41.

Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT et al..  2001.  Laminin-5-mediated gene expression in human prostate carcinoma cells.. Mol Carcinog. 30(2):119-29.